Press Releases :: Moleculin Biotech, Inc. (MBRX)

Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

Feb 20, 2019

Moleculin Announces Approval for Third Drug to Commence Clinical Trials

Feb 7, 2019

Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug

Feb 5, 2019

Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board

Jan 17, 2019

Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland

Jan 9, 2019

Moleculin Announces Positive Data for its Pancreatic Cancer Drug Candidate

Jan 3, 2019

REMINDER: Moleculin Announces Conference Call to Discuss Recent Breakthrough Discovery and FDA Filing on Wednesday, December 12, 2018

Dec 11, 2018

Moleculin Announces Conference Call to Discuss FDA Filing and New Immune Checkpoint Data on Wednesday, December 12, 2018

Dec 6, 2018

Moleculin Announces FDA Filing for Orphan Drug Designation for Glioblastoma Drug

Dec 6, 2018

Moleculin Announces Breakthrough Discovery for its WP1066

Dec 4, 2018